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The pancreatic islet and the adenohypophysis 
are endocrine tissues haring several proper- 
ties. These organs are both composed of 
different endocrine cells secreting a variety of 
hormones. These are stored within the cells 
in dense core secretory vesicles and are 
released by appropriate stimuli. In addition to 
dense core secretory vesicles, endocrine pan- 
creatic and adenohypophyseal ce ls contain 
small translucent vesicles, which are very 
similar to synaptic vesicles not only in their 
morphological appearance but also with 
regard to their protein constituents [31, 64]. 
Indeed, several lines of evidence suggest that 
pancreatic and adenohypophyseal ndocrine 
cells have an additional secretory pathway for 
neurotransmitters besides the classic exocy- 
totic pathway for hormone release [31, 54, 
60]. Proteins present in the dense core 
vesicles containing hormones, such as chro- 
mogranins and secretogranins, have also been 
detected in their counterparts within neurons 
(for refs. see [30, 37, 38, 61]). This indicates 
that neurons and endocrine ceils are very 
similar with respect o the composition of 
their characteristic small secretory vesicles 
(SSV) and large secretory vesicles (LSV) 
besides having a variety of molecular, bio- 
chemical, and functional similarities [25]. 
Neurons and endocrine cells also share 
proteins exposed on the external surface. The 
best documented proteins of this class are 
members of the family of neural cell adhesion 
molecules (NCAMs), which are present in 
endocrine cells of the adult, including pancre- 
atic islet and adenohypophyseal cells [2, 
39-41]. While tumors derived from the 
endocrine pancreas are rare [35], pituitary 
tumors are frequently observed [27, 35, 73]. 
Besides symptoms produced locally by the 
tumors, overproduction of their hormones 
and their subsequent effects in the body often 
permit a straightforward diagnosis. However, 
a significant percentage of endocrine pancre- 
atic and pituitary tumors do not cause 
elevated serum hormone levels and thus are 
hormonally inactive [27, 29, 73]. In such 
cases additional characteristic onstituents of 
endocrine cells are critical in providing 
information on the nature, location, and 
distribution of endocrine tumor cells in the 
body. Here we summarize recent findings 
concerning the expression of membrane 
proteins of SSV and of the cell surface antigen 
NCAM by normal and neoplastic endocrine 
cells. 
Membrane Proteins of Small 
Secretory Vesicles and the Cell 
Surface 
Studies on the composition of synaptic 
vesicles of neurons have provided detailed 
information on the composition of their 
membranes [6, 31, 64]. Although many of 
these membrane proteins are also present in 
endocrine cells, few have been shown to be 
present in the SSVs of normal pancreatic islet 
or adenohypophyseal ndocrine cells or of 
pituitary and pancreatic endocrine tumors. 
Thus the application of analysis of membrane 
SSV antigens in pathology is largely restricted 
to the analysis of synaptophysin, which, like 
the neural cell adhesion molecule NCAM, 
has been detected by at least three indepen- 
dent research groups [9, 32, 69]. 
Synaptophysin is a highly conserved 
protein consisting of four transmembrane 
domains in addition to a short N-terminal 
and an extended C-terminal cytoplasmic 
domain [6, 31, 64]. Recently discovered 
homologs like synaptoporin and their avian 
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counterparts have a similar structure [8, 36]. 
These and other synaptic vesicle membrane 
proteins, termed synaptotagmin a d vesicle 
associated membrane protein (VAMP), have 
closely related isoforms that are differentially 
distributed in the central nervous ystem [22, 
46, 47, 67]. It is not yet known whether the 
isoforms of synaptic vesicle membrane pro- 
teins are also differentially distributed be- 
tween endocrine cells. In addition, reports 
from several groups uggest that some mem- 
brane proteins or their isoforms may be 
shared by SSV and LSVs [22, 31, 45, 52, 58, 
59]. In neurons, the membrane proteins of 
synaptic vesicles are involved in transmitter 
uptake, exocytosis, and membrane recycling 
[7, 10, 64]. The SSVs of endocrine cells, 
which bear the same antigens as synaptic 
vesicles, may fulfil similar roles. However, 
data concerning the biosynthesis of neuro- 
transmitters, their uptake into SSVs, and their 
release from endocrine cells such as the 
pancreatic slet or adenohypophyseal cells are 
still fragmentary [54, 60]. However, the same 
processes that occur during hormone release 
from LSVs are well understood. 
Intercellular contacts via cell adhesion 
molecules are critical during embryonic 
development. Neural cell adhesion mole- 
cules, including NCAM, NgCA/Vl, and N- 
cadherins, have been shown to participate in 
celt sorting, cell assembly, and tissue reorgani- 
zation [11, 16, 56]. Also, in the adult, 
NCAMs persist in strategic locations, suggest- 
ing their importance in the maintenance of
tissue architecture. Endocrine cells of the 
adenohypophysis, the pancreatic islets, and 
the gonads adhere to each other by means of 
NCAMs [2, 39-41, 48, 49]. 
The different members of the NCAM 
family are translation products of different 
messenger RNAs generated by alternative 
splicing and differential polyadenylation from 
a single gene consisting of at least 24 exons. 
The three major NCAM isoforms have 
similar extracellular domains, and they differ 
primarily in their plasma membrane associ- 
ated domains and the lengths of their 
intracellular domains. For example, NCAM 
180 (the isoform with a molecular weight of 
180 kD) has a cytoplasmic domain that is 
larger than that of NCAM 140, whereas 
NCA/Vl 120 consists only of the extracellular 
domain, which is anchored to the plasma 
membrane by phosphatidylinositol [11, 16, 
41, 51, 56]. In addition to the production of 
the different membrane associated and cyto- 
plasmic domains of the three major NCAM 
isoforms, alternative splicing of minor exons 
gives rise to variations in those regions of the 
extracellular NCA/Vl domains that mediate 
cell adhesion. For example, at the exon 12/13 
junction, coding for the presumptive hinge 
region of the molecule, smaller additional 
alternative xons of different lengths were 
present, which are inserted by alternative 
splicing. In addition, at the exon 7/S junction, 
an exon coding for a further 10 amino acids 
has been detected in several cell types (for 
refs. see [3]). This modification within the 
fourth immunoglobulin-like extracellular do- 
main of NCAM down-regulates neurite 
growth-promoting activity of NCAM 140 
[15]. Posttranslational modifications involv- 
ing addition of polysialic acid (PSA) ho- 
mopolymers to the extracellular domain of 
NCAM can occur. The polysialylation of 
NCAM decreases cell-cell adhesion and is 
thus of functional importance [1, 55]. 
Expression of Synaptophysin and 
NCAM in Human Pancreatic Islets 
and Endocrine Pancreatic Tumors 
In all species examined including humans, 
synaptophysin has been detected in all endo- 
crine pancreatic cell types [50, 53, 70, 71]. 
Since synaptophysin has also been found in 
all pancreatic endocrine tumors examined 
[24, 70-72], this protein can be regarded as a 
general marker for these tumors. Insulinomas 
are the most frequent of the relatively rare 
endocrine pancreatic tumors (for refs. see 
[35]). They have been reported to contain 
synaptophysin [24, 30, 70, 71]. Figures la and 
lb show a typical insulinoma exhibiting 
immunoreactivity for insulin and synaptophy- 
sin. The strong hybridization signal for 
synaptophysin mP2qA observed in the same 
tumor (Fig. lc) indicates that both transcrip- 
tion and translation of synaptophysin are 
typical features of such tumors. Other marker 
proteins uch as chromogranin A, which is 
present in all endocrine cell types in bovine 
pancreatic slets [17, 18], is present in A cells 
in humans and at lower levels in human B 
cells, but is apparently absent from D and PP 
cells [26]. Interestingly, endocrine pancreatic 
tumors that are immunoreactive for soma- 
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Figure 1. Human insulinoma expressing synaptophysin, chromogranin A, and NCAM. Immunolocalization of insulin (a) and synapto- 
physin (b) in a human insulinoma. A strong hybridization signal for synaptophysin mRNA was observed in sections of the same tumor (c). 
The insulinoma was also immunostained for chromogranin A (d) and showed a positive hybridization signal for NCAM mRNA (e). Synapto- 
physin mRNA was visualized byin situ hybridization [5] with a cRNA directed against the sequence coding for the C-terminal cytoplasmic 
tail of the molecule [42]. For NCAM mRNA detection we used a cRNA probe directed against parts (exon 13/14) of the extracellular do- 
main of NCAM [23]. (x340). 
tostatin or pancreatic polypeptide have been 
reported to contain chromogranin A (see refs. 
[30]), which may indicate that, compared to 
normal counterparts, chromogranin A expres- 
sion is up-regulated in D- and PP-secreting 
tumors. Tissue-specific expression of chro- 
mogranin A appears to be regulated by several 
transcriptional control elements. A cyclic 
AMP responsive lement has recently been 
detected in the chromogranin A promoter 
region [74]. Its activation may also occur in 
insulinomas which contain elevated levels of 
chromogranin A as compared to the weak 
immunostaining of human pancreatic B cells 
[26]. Prominent immunostaining for chro- 
mogranin A in a human insulinoma is shown 
in Fig. ld. 
Recently it was observed that expression 
of the neural cell adhesion molecule NCAM 
not only is a general feature of the endocrine 
cell types constituting the rat pancreatic islet, 
but also is characteristic of a rat insulinoma 
cell line [39, 40]. NCAM 140 is the prevalent 
isoform in normal and neoplastic endocrine 
pancreatic ells. NCAM transcripts have also 
been detected in one human insulinoma [33]. 
Moreover, the insulinoma immunostained 
for chromogranin A and synaptophysin shown 
here exhibited hybridization signals not only 
for synaptophysin but also for NCAM 
mRNA (Fig. le). Thus it can be concluded 
that the expression of synaptophysin, chro- 
mogranin A, and NCAM is a typical feature 
of human insulinomas. 
Cell surface components as marker sub- 
stances present several advantages compared 
with intracellular molecules. They are accessi- 
ble to external molecules and could be used 
for immunoscintigraphy. It is conceivable 
that antibodies could be used to target drugs 
to tumors expressing NCAM. Surface mark- 
ers such as NCAM could also be valuable for 
cytological diagnosis on biopsies or bone 
marrow aspirates. Besides NCAM, only 
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tetanus toxin binding sites, which are present 
at the surface of pancreatic islet cells and 
human insulinoma cells [19], could be used 
for similar purposes. However, tetanus toxin 
binding occurs only initially at the cell surface 
and is followed by internalization fthe toxin 
and its action within the cells. Thus not only 
the receptors of tetanus toxin at the cell 
surface but also its target inside the ceils, 
which is present in endocrine but not in 
exocrine cells (cf refs. [62]), may provide 
further marker molecules for endocrine cells. 
Expression of Synaptophysin and 
NCAM in Human 
Adenohypophyses and 
Pituitary Tumors 
Following the first report on the presence of 
synaptophysin rodent adenohypophyses 
[50] several articles published in 1987-88 
documented itspresence also in normal and 
neoplastic pituitary cells of humans (cf refs. 
[71, 2, 24, 63]). M1 reports agree that he SSV 
antigen exists in all these cells, indicating that 
synaptophysin can be used as a general 
marker for pituitary cells (Fig. 2a), as is the 
case for endocrine pancreatic cells (see 
above). 
In contrast, the distribution of other 
markers in normal and neoplastic hypophy- 
seal cells is not so homogeneous. For 
example, most investigators agree that chro- 
mogranin A is not present either in normal 
prolactin cells or in prolactinomas, whereas 
chromogranin A has been frequently detected 
in human GH adenomas [14, 30, 43, 44, 63]. 
Acidophil pituitary adenomas produce growth 
hormone (GH), prolactin, or both (cf refs. 
[29]). Thus acidophil adenoma cells may be 
distinguished by the prevalence of the hor- 
mones expressed and be regarded as a 
bihormonal cell type, in which the transcrip- 
tion and translation of hormones and other 
characteristic constituents i  regulated by 
hypothalamic, gonadal, and adrenal steroids 
in addition to other factors (cf refs. [21]). In 
this context it is interesting to note that the 
chromogranin A and prolactin genes share 
similar promoter/enhancer elements [21, 
74], which would allow parallel regulation of 
both substances (e.g., via dopamine and 
cAMP) in normal and neoplastic ells. In 
both promoter egions there is a cis-acting 
cyclic AMP responsive element termed CRE 
[34]. CRE is a target site for the transcription 
factor CREB (cyclic AMP responsive element 
binding protein), which shares many features 
with the fos-jun family of transcription 
factors [75]. Steroid hormones can also act as 
transcriptional ctivators by binding of the 
hormone-receptor c mplex in the promoter 
region of the gene. Estrogen receptors are 
clearly involved in enhancement of prolactin 
gene expression [21], and there is evidence 
that chromogranin A expression is also 
affected by estrogen [20]. While hormone 
and chromogranin levels in the pituitary 
acidophils can be varied in this way, it is not 
entirely clear whether growth hormone, 
Figure 2. Human GH adenoma expressing synaptophysin and NCAM. Apparently all cells of the human GH adenoma exhibited intra- 
cellular immunolabeling for synaptophysin (a) while their surfaces were immunolabeled for NCAM (b). In situ hybridization histochemistry 
revealed that only some cells of the adenoma expressed NCAM mRNA (c). (• The nature of the NCAM probe is described in legend 
to Fig. I. 
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prolactin, and chromogranins are stored 
together in the same or in different secretory 
vesicles [4]. In the bihormonal FSH/LH cells 
chromogranin A is confined exclusively to the 
large dense core secretory vesicles [68]. 
Like chromogranin A, neural cell adhe- 
sion molecules are differentially expressed in
human pituitary tumors [2, 25]. While GH 
adenomas and inactive adenomas express 
NCAM 140 at levels that permit easy 
identification i immunoblots, NCAM could 
not be detected by such techniques in 
prolactinomas. Its presence could be con- 
firmed by immunoelectron microscopy [2] 
and also in one prolactinoma by immunocyto- 
chemistry and in situ hybridization histo- 
chemistry [33]. These data are indicative of 
low levels of NCAM in prolactinomas and 
higher levels in GH adenomas. Intense 
immunocytochemical staining for NCAM of 
a GH adenoma is shown in Fig. 2b. In situ 
hybridization histochemistry (see Fig. 2c) 
revealed that only some groups of cells 
express NCAM mRNA at a given time, 
whereas the translated protein appears to be 
more evenly distributed in the tumor cells 
(Fig. 2b). 
With one exception NCAM 140 was 
detectable in hormonally inactive adenomas 
[2]. It seems likely that levels of prolactin 
were below the sensitivity limits ofimmuno- 
cytochemistry in the inactive adenoma, which 
appeared negative for NCAM. Such adeno- 
mas have recently been reported to contain 
prolactin mRNA [57]. The presence of" 
NCAM in most inactive adenomas has 
recently been confirmed [33]. Clearly there 
now exists a variety of diagnostic markers for 
inactive adenomas, which are frequent and by 
definition cannot be identified by hormone 
analyses. Besides cytoplasmic neuron-specific 
enolase, NCAM, and synaptophysin, they 
produce and release chromogranin A, which 
can be analyzed not only by immunocyto- 
chemistry but also in serum [12, 13, 65, 66]. 
The differences in the expression of hor- 
mones, chromogranin A, and NCAM be- 
tween pituitary acidophil adenomas, which 
have been reported, are of particular interest. 
The pattern of expression of these proteins 
could be explained by the fact that their 
transcription is regulated by closely related 
transcription factors [21, 28, 74]. 
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